Why we measure it

Each sub-panel within the CMP provides a different early-warning signal. The renal component detects declining kidney function before it becomes symptomatic — eGFR typically needs to fall below 60 mL/min/1.73m² before creatinine rises above the reference range, making eGFR the more sensitive early marker. Chronic kidney disease (CKD) is estimated to affect approximately 10% of adults globally, the majority unaware of their diagnosis because early CKD produces no symptoms. The hepatic component detects liver injury from any cause — metabolic-associated fatty liver disease (MAFLD), medication hepatotoxicity, alcohol-related liver disease, or autoimmune hepatitis. ALT is the most liver-specific marker of hepatocellular injury; elevated GGT is particularly sensitive to alcohol use and non-alcoholic fatty liver disease even when ALT is normal. Albumin reflects hepatic synthetic function and nutritional status — a falling albumin is a late but significant signal of chronic liver disease or protein malnutrition. The electrolyte panel detects acid-base and fluid-electrolyte disturbances from any cause, including diuretic use, GI losses, adrenal dysfunction, and renal tubular disease. Quarterly CMP tracking turns each of these into a trend line rather than a one-time snapshot — a gradually rising ALT over four quarters, each individually within range, is a clinically meaningful finding that a single annual measurement would not reveal.

Why every 3 months

The components of the CMP respond on different timescales. ALT and AST can rise within days of a hepatic insult and fall over weeks as the injury resolves. eGFR changes slowly in stable CKD — a 3-5 mL/min/1.73m²/year decline is clinically significant. Electrolytes are tightly regulated and only deviate with significant perturbation. Quarterly measurement provides sufficient temporal resolution to detect the slowly evolving changes (liver disease, CKD progression) while also catching transient abnormalities (medication effect, intercurrent illness) that may return to normal without intervention but warrant noting in the record.

What movement means

The CMP is a multi-component panel. The clinically most informative sub-components are eGFR (renal filtration), ALT (liver injury), and albumin (hepatic synthesis and nutritional status). Reference ranges are laboratory-specific.

In the protocol